← Eichor
Condition: Corneal Epithelial Disorders Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Corneal Epithelial Disorders

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Effects of 3% Trehalose Ophthalmic Solution on Corneal Epithelial Barrier Function
Phase 4 · 1 location(s) · Southern California College of Optometry at Marshall B. Ketc · NCT06655441
Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease
Phase 2 · 1 location(s) · University of Illinois at Chicago · NCT06919081
An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED
Phase 3 · 77 location(s) · Dompé Farmaceutici S.p.A · NCT07519902
Cultured Autologous Oral Mucosa Epithelial Sheet for the Treatment of Bilateral Limbal Stem Cell Deficiency
Phase 1/Phase 2 · 1 location(s) · Hospices Civils de Lyon · NCT03949881
Lacripep for Corneal Wound Healing Study
Phase 2 · 1 location(s) · Henry M. Jackson Foundation for the Advancement of Military · NCT06854393
A Single-Center Clinical Study to Evaluate the Efficacy and Safety of Autologous Urine-Derived Epithelial Cells in the T
NA · 1 location(s) · Suxia Li · NCT07435142
PRoTECT: Corneal Wavefront Guided PRK + Epi-off CXL vs. PTK+Epi-off CXL in Keratoconus
NA · 1 location(s) · Instituto de Oftalmología Fundación Conde de Valenciana · NCT07372911
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.